Evidence map›Paper›PMID 27280729›Full record

ArticlePLoS neglected tropical diseases2016

Stabilising the Integrity of Snake Venom mRNA Stored under Tropical Field Conditions Expands Research Horizons.

Gareth Whiteley, Rhiannon A E Logan, Kam-Yin D Leung, Fiona J Newberry, Paul D Rowley, John P Dunbar, Simon C Wagstaff, Nicholas R Casewell, Robert A Harrison

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Modern trends in animal venom research - omics and nanomaterials.World journal of biological chemistry · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Gareth WhiteleyAlistair Reid Venom Research Unit, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.ORCID 0000-0001-7828-6270
Rhiannon A E LoganAlistair Reid Venom Research Unit, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Kam-Yin D LeungAlistair Reid Venom Research Unit, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Fiona J NewberryAlistair Reid Venom Research Unit, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Paul D RowleyAlistair Reid Venom Research Unit, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
John P DunbarAlistair Reid Venom Research Unit, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Simon C WagstaffBioinformatics Unit, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Nicholas R CasewellAlistair Reid Venom Research Unit, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Robert A HarrisonAlistair Reid Venom Research Unit, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Liverpool School of Tropical Medicine · GB

Funding

Medical Research Council MR/L01839X/1National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/K500288/1
6 · The paper itself

Abstract

backgroundSnake venoms contain many proteinaceous toxins that can cause severe pathology and mortality in snakebite victims. Interestingly, mRNA encoding such toxins can be recovered directly from venom, although yields are low and quality is unknown. It also remains unclear whether such RNA contains information about toxin isoforms and whether it is representative of mRNA recovered from conventional sources, such as the venom gland. Answering these questions will address the feasibility of using venom-derived RNA for future research relevant to biomedical and antivenom applications. METHODOLOGY/PRINCIPAL

findingsVenom was extracted from several species of snake, including both members of the Viperidae and Elapidae, and either lyophilized or immediately added to TRIzol reagent. TRIzol-treated venom was incubated at a range of temperatures (4-37°C) for a range of durations (0-48 hours), followed by subsequent RNA isolation and assessments of RNA quantity and quality. Subsequently, full-length toxin transcripts were targeted for PCR amplification and Sanger sequencing. TRIzol-treated venom yielded total RNA of greater quantity and quality than lyophilized venom, and with quality comparable to venom gland-derived RNA. Full-length sequences from multiple Viperidae and Elapidae toxin families were successfully PCR amplified from TRIzol-treated venom RNA. We demonstrated that venom can be stored in TRIzol for 48 hours at 4-19°C, and 8 hours at 37°C, at minimal cost to RNA quality, and found that venom RNA encoded multiple toxin isoforms that seemed homologous (98-99% identity) to those found in the venom gland. CONCLUSIONS/SIGNIFICANCE: The non-invasive experimental modifications we propose will facilitate the future investigation of venom composition by using venom as an alternative source to venom gland tissue for RNA-based studies, thus obviating the undesirable need to sacrifice snakes for such research purposes. In addition, they expand research horizons to rare, endangered or protected snake species and provide more flexibility to performing fieldwork on venomous snakes in tropical conditions.

Indexed as

Amino Acid SequenceAnimalsElapidaeGuanidinesPhenolsRNA, MessengerSnake VenomsSpecimen HandlingTemperatureTropical ClimateViperidaeGuanidinesPhenolsRNA, MessengerSnake Venomstrizol

Identifiers

PMID27280729
PMCPMC4900621
OpenAlexW2413556455

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.